Khadijah Hassan Muzaffar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Khadijah Hassan Muzaffar has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Hafez Mousa
Neurosciences, Dubai Health, Dubai, United Arab Emirates
1 shared publication Asim Muhammed Alshanberi
Department of Community Medicine and Pilgrims Health Care, Umm Alqura University, Makkah, 24382, Saudi Arabia
1 shared publicationHassan Mohammed Rezk
Department of Human Anatomy and Embryology, Mansoura University, Mansoura, Egypt
1 shared publication- Salwa Agha Mohammad
Batterjee Med Coll, Med Program, Jeddah 21442, Saudi Arabia
1 shared publication Shakeel Ahmed Ansari
Department of Biochemistry, Batterjee Medical College, Jeddah, Makkah, 21442, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 25 August 2021
- Published by F1000 Research Ltd in F1000Research
- Vol. 10, 850
Nanoparticles in traumatic spinal cord injury: therapy and diagnosis
Nanotechnology has been previously employed for constructing drug delivery vehicles, biosensors, solar cells, lubricants and as antimicrobial agents. The advancement in synthesis procedure makes it possible to formulate nanoparticles (NPs) with precise control over physico-chemical and optical properties that are desired for specific clinical or biological applications. The surface modification technology has further added impetus to the specific applications of NPs by providing them with desirable characteristics. Hence, nanotechnology is of paramount importance in numerous biomedical and industrial applications due to their biocompatibility and stability even in harsh environments. Traumatic spinal cord injuries (TSCIs) are one of the major traumatic injuries that are commonly associated with severe consequences to the patient that may reach to the point of paralysis. Several processes occurring at a biochemical level which exacerbate the injury may be targeted using nanotechnology. This review discusses possible nanotechnology-based approaches for the diagnosis and therapy of TSCI, which have a bright future in clinical practice.
- 25 August 2021
- Published by F1000 Research Ltd in F1000Research
- Vol. 10, 850
Open AccessNanoparticles in traumatic spinal cord injury: therapy and diagnosis
Nanotechnology has been previously employed for constructing drug delivery vehicles, biosensors, solar cells, lubricants and as antimicrobial agents. The advancement in synthesis procedure makes it possible to formulate nanoparticles (NPs) with precise control over physico-chemical and optical properties that are desired for specific clinical or biological applications. The surface modification technology has further added impetus to the specific applications of NPs by providing them with desirable characteristics. Hence, nanotechnology is of paramount importance in numerous biomedical and industrial applications due to their biocompatibility and stability even in harsh environments. Traumatic spinal cord injuries (TSCIs) are one of the major traumatic injuries that are commonly associated with severe consequences to the patient that may reach to the point of paralysis. Several processes occurring at a biochemical level which exacerbate the injury may be targeted using nanotechnology. This review discusses possible nanotechnology-based approaches for the diagnosis and therapy of TSCI, which have a bright future in clinical practice.